Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Drug efficacy

Research reveals 15% failure rate for antibiotics prescribed for common infections

GPs need to better manage patients’ expectations and carefully consider whether each prescription for antibiotics is justified.

Antibiotics prescribed for common infections have a 15% failure rate, research reveals

Source: Shutterstock.com

The rate of increase in antibiotic treatment failure was less prominent with the most commonly prescribed antibiotics, researchers find

Antibiotics prescribed by GPs in 2012 for four common infections failed in 15% of cases, according to an analysis of data in the UK Clinical Practice Research Datalink[1].

The researchers examined nearly 11 million prescriptions for antibiotics as a first-line and single treatment for upper and lower respiratory tract infections, skin and soft tissue infections and acute otitis media. To assess treatment failure rates, they tracked further prescriptions for antibiotics issued within 30 days or looked for other markers, such as an admission to hospital with an infection-related diagnosis or referrals to infection-related specialist services.

The rate of failure of 15.4% in 2012 is an increase from 13.9% in 1991. Most of this increase occurred after 2000 when antibiotic prescribing, which had plateaued, began to rise again.

“We have shown that in primary care, where most antibiotics are prescribed, and in a developed country, the impact of increasing antibiotic treatment failure was not as great as we had anticipated based on evidence reported from hospital settings with more severe infections,” they write.

“Another interpretation of these data, however, would be that the observed rates are in reality higher because inappropriate or unnecessary prescribing could have attenuated the failure rates.”

The analysis also reveals that the rate of increase in antibiotic treatment failure was less prominent with the most commonly prescribed antibiotics and in those recommended for first-line treatment, such as broad spectrum penicillins (e.g., amoxicillin) and the macrolides (clarithromycin and erythromycin).

But there were notable increases in failure rates for certain antibiotics that are usually not recommended as first-line treatments for the four conditions, such as trimethoprim, the cephalosporins and the quinolones. “Such drugs, however, might have been prescribed for more severely ill and frail patients who had recently been prescribed a first-line drug or from whom resistant organisms had been previously isolated.”

The researchers, led by Craig Currie a professor of applied pharmacoepidemiology at Cardiff University, say they are unable to conclude whether the increased failure rate is a phenomenon that will resolve or whether it is an early indication of a more dramatic and worrying process.

“Nevertheless, the finding that treatment failure was associated with more than one in ten initial antibiotic treatments in primary care represents a considerable burden on patients and on the healthcare systems.”

The data suggest that primary care physicians can play a central role in helping to contain rises in antibiotic treatment failure, the researchers argue. This could be achieved by better managing patients’ expectations and carefully considering whether each prescription is justified.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066704

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • MCQs in Clinical Pharmacy

    MCQs in Clinical Pharmacy

    Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.

    £25.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • International Research in Healthcare

    International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.